Key facts
- ACCELStars’s last known valuation is $48.3M (Mar 2026).
- It has raised $16.5M; the latest was Later Stage VC ($4.5M) in Mar 2026.
- Notable investors include Japan External Trade Organization, FFG Venture Business Partners, Sumitomo Mitsui Trust Bank, Suzuyo, Sumitomo Life Insurance Company — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for ACCELStars
- ·The full record, as it builds
Funding rounds
No funding rounds for ACCELStars are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ACCELStars
Developer of healthcare technology designed to measure sleep with precision and support diagnostic assessment of sleep disorders, operating in the sleep medicine and clinical research sector. The company offers medical-grade wearables and analytical algorithms that detect sleep apnea and related conditions outside clinical settings, a platform that includes corporate sleep-improvement programs, digital biomarker analytics, and diagnostic support tools for hospitals, enabling organizations and researchers to improve screening efficiency, support clinical decision-making, and population-level evidence generation.
- Sector
- Healthcare
- HQ
- Kurume, Japan
- Founded
- 2020
- Employees
- 19
- Website
- accelstars.com/
- Ownership
- Privately Held (backing)
ACCELStars doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ACCELStars shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ACCELStars in its N-PORT filings yet. We sweep new filings monthly.